CDHA CAAR

June 18, 2021

CAAR – US Senate Special Committee on Aging Hearing Testimony – June 18, 2021

Filed under: Legislation Information Updates — Tags: , — admin @ 4:28 pm

21st Century Caregiving: Supporting Workers, Family Caregivers, Seniors and People with Disabilities,” a hearing held June 17, 2021 (witness statements available in .pdf format, video of the full hearing available at the site, running time 1 hour 41 minutes). Note: The hearing starts at the 18:33 mark.

www.aging.senate.gov/hearings/-21st-century-caregiving-supporting-workers-family-caregivers-seniors-and-people-with-disabilities

CAAR – US House Committee on Ways and Means, Social Security Subcommittee Hearing Testimony – June 18, 2021

Filed under: Legislation Information Updates — Tags: — admin @ 4:26 pm

Equity in Social Security: In Their Own Words,” a hearing held June 15, 2021 (witness statements available in .pdf format, video of the full hearing available at the site, running time 1 hour 52 minutes). Note: The hearing starts at the 24:10 mark.

waysandmeans.house.gov/legislation/hearings/social-security-subcommittee-hearing-equity-social-security-their-own-words

CAAR – US National Institutes of Health Funding Opportunities – June 18, 2021

Filed under: Employment/Funding Opportunities — Tags: — admin @ 4:25 pm

A. “Role of Adaptive Immunity in Etiology of Alzheimer’s Disease and Alzheimer’s Disease-Related Dementias (R01 Clinical Trial Optional),” (RFA-AG-22-017, National Institute on Aging, application deadline Oct. 28, 2021).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-22-017.html

B. “Leveraging Existing Large Databases and Cohorts to Better Understand the Risks and Benefits of Long-Term Osteoporosis Therapy and Drug Holiday (R01 Clinical Trial Not Allowed),” (RFA-AG-22-018, National Institute on Aging, in conjunction with other agencies, application deadline Oct. 28, 2021).

grants.nih.gov/grants/guide/rfa-files/RFA-AG-22-018.html

CAAR – Lancet Neurology Article – June 18, 2021

Filed under: Reports and Articles — Tags: — admin @ 4:23 pm

Note: Check with your organization’s library for availability. “Safety and efficacy of pioglitazone for the delay of cognitive impairment in people at risk of Alzheimer’s disease (TOMMORROW): a prognostic biomarker study and a phase 3, randomised, double-blind, placebo-controlled trial,” by Daniel K. Burns, Robert C. Alexander, Kathleen A. Welsh-Bohmer, Meredith Culp, Carl Chiang, Janet O’Neil, Rebecca M. Evans, Patrick Harrigan, Brenda L. Plassman, James R. Burke, Jingtao Wu, Michael W. Lutz, Stephen Haneline, Adam J. Schwarz, Lon S. Schneider, Kristine Yaffe, Ann M. Saunders, and Emiliangelo Rattion behalf of the TOMMORROW study investigators (Vol. 20, No. 7, July 2021, p. 537-547).

www.thelancet.com/journals/laneur/article/PIIS1474-4422(21)00043-0/fulltext

CAAR – AARP Public Policy Institute Report – June 18, 2021

Filed under: Reports and Articles — Tags: — admin @ 4:23 pm

Concurrent Anticholinergic and Acetylcholinesterase Inhibitor Drug Use Among Older Adults with Dementia: Commonly Done; Never Advised,” by Elizabeth A. Carter and Erwin J. Tan (June 2021, .pdf format, 4p.).

www.aarp.org/ppi/info-2021/concurrent-inhibitor-drug-use-among-older-adults-with-dementia.html

CAAR – Institute for the Study of Labor (IZA) [University of Bonn, Germany] Working Paper – June 18, 2021

Filed under: Working Papers — Tags: , , — admin @ 4:21 pm

Pension Incentives and Labor Supply: Evidence from the Introduction of Universal Old-Age Assistance in the UK,” by Matthias Giesecke and Philipp Jaeger (Discussion Paper No. 14469, June 2021, .pdf format, 66p.). Note: A link to the abstract and the full-text of this paper is available at:

www.iza.org/publications/dp/14469

Powered by WordPress